Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-β-deposits
dc.contributor.author | Dinamarca, M. C. | |
dc.contributor.author | Cerpa, W. | |
dc.contributor.author | Garrido, J. | |
dc.contributor.author | Hancke, J. L. | |
dc.contributor.author | Inestrosa, N. C. | |
dc.date.accessioned | 2025-01-21T01:05:50Z | |
dc.date.available | 2025-01-21T01:05:50Z | |
dc.date.issued | 2006 | |
dc.description.abstract | The major protein constituent of amyloid deposits in Alzheimer's disease (AD) is the amyloid beta-peptide (A beta). In the present work, we have determined the effect of hyperforin an acylphloroglucinol compound isolated from Hypericum perforatum (St John's Wort), on A beta-induced spatial memory impairments and on A beta neurotoxicity. We report here that hyperforin: ( 1) decreases amyloid deposit formation in rats injected with amyloid fibrils in the hippocampus; ( 2) decreases the neuropathological changes and behavioral impairments in a rat model of amyloidosis; ( 3) prevents A beta-induced neurotoxicity in hippocampal neurons both from amyloid fibrils and A beta oligomers, avoiding the increase in reactive oxidative species associated with amyloid toxicity. Both effects could be explained by the capacity of hyperforin to disaggregate amyloid deposits in a dose and time-dependent manner and to decrease A beta aggregation and amyloid formation. Altogether these evidences suggest that hyperforin may be useful to decrease amyloid burden and toxicity in AD patients, and may be a putative therapeutic agent to fight the disease. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1038/sj.mp.4001866 | |
dc.identifier.eissn | 1476-5578 | |
dc.identifier.issn | 1359-4184 | |
dc.identifier.uri | https://doi.org/10.1038/sj.mp.4001866 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/96028 | |
dc.identifier.wosid | WOS:000241578100008 | |
dc.issue.numero | 11 | |
dc.language.iso | en | |
dc.pagina.final | 1048 | |
dc.pagina.inicio | 1032 | |
dc.revista | Molecular psychiatry | |
dc.rights | acceso restringido | |
dc.subject | amyloid-beta-peptide | |
dc.subject | hyperforin | |
dc.subject | neurotoxicity | |
dc.subject | spatial learning | |
dc.subject | disaggregation | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-β-deposits | |
dc.type | artículo | |
dc.volumen | 11 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |